Management of Newly Diagnosed Symptomatic Multiple Myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus GuidelinesShaji Kumar, P. Leif Bergsagel|Mayo Clinic Proceedings|2009Cited by 625
Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working GroupPhilippe Moreau, Jean‐Luc Harousseau, Evangelos Terpos et al.|The Lancet Oncology|2021Cited by 266
Gene-expression profiling of Waldenstrom macroglobulinemia reveals a phenotype more similar to chronic lymphocytic leukemia than multiple myelomaWee Joo Chng, P. Leif Bergsagel|Blood|2006Cited by 182
Abstract 6253: SP-3164, a novel molecular glue degrader with activity in preclinical models of multiple myelomaAundrietta D. Duncan, P. Leif Bergsagel, Daniela Y. Santiesteban et al.|Cancer Research|2023Cited by 1